PLAY PODCASTS
OncLive® On Air

OncLive® On Air

OncLive® On Air · Audioboom

524 episodesEN

Show overview

OncLive® On Air has been publishing since 2022, and across the 4 years since has built a catalogue of 524 episodes. That works out to roughly 150 hours of audio in total. Releases follow a several-times-a-week cadence, with the show now in its 16th season.

Episodes typically run ten to twenty minutes — most land between 11 min and 21 min — though episode length varies meaningfully from one episode to the next. None of the episodes are flagged explicit by the publisher. It is catalogued as a EN-language Health & Fitness show.

The show is actively publishing — the most recent episode landed 2 days ago, with 103 episodes already out so far this year. The busiest year was 2025, with 172 episodes published. Published by Audioboom.

Episodes
524
Running
2022–2026 · 4y
Median length
15 min
Cadence
Several per week

From the publisher

In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers, hematologic malignancies, gynecologic cancers, genitourinary cancers, and more.

Latest Episodes

View all 524 episodes

S17 Ep22: Answering Key Clinical Questions About Esophageal Cancer Care: With Peter Enzinger, MD

May 13, 20269 min

S17 Ep23: FDA Approval Insights: Brexu-Cel for Relapsed/Refractory MCL: With Luhua (Michael) Wang, MD

May 13, 202620 min

S17 Ep21: Honesty and Humor Provide Hope in Breast Cancer Survivorship: With Sara Nunnery, MD, MSCI; and Annie Bond

May 12, 202648 min

S17 Ep20: Biomarker-Directed Therapies Move the GI Oncology Paradigm Beyond a One-Size-Fits-All Approach: With Michael J. Pishvaian, MD, PhD

May 8, 202622 min

S17 Ep19: Cases and Conversations™: Next-Generation Pathology Advances and Considerations for Precision Care in Non–Small Cell Lung Cancer

May 6, 202630 min

S17 Ep18: Metastatic Bladder Cancer 2026 UPDATE

May 4, 20269 min

S17 Ep16: Show Me the Data®: From Mutation to Action—KRAS as a Therapeutic Target in PDAC

May 1, 202630 min

S17 Ep15: FES-PET/CT Reshapes Treatment Planning in Lobular Breast Cancer and Beyond: With Megan Kruse, MD

May 1, 202615 min

S17 Ep14: Treatment Advances in Relapsed SCLC Introduce New Options and Clinical Workflows: With Alissa Cooper, MD

Apr 30, 202627 min

S17 Ep13: Cases and Conversations: Translating ctDNA Into Clinical Decisions in Breast Cancer

Apr 30, 202625 min

S17 Ep12: ADCs Change Treatment Paradigms and Challenge Standard AE Management Protocols in TNBC: With Sara Nunnery, MD, MSCI; and Irene Morae Kang, MD

Apr 30, 202647 min

S17 Ep11: Medical Crossfire® — From Diagnostic Dilemmas to Potential Treatment Breakthroughs: Exploring Novel Targets for Extrapulmonary Neuroendocrine Carcinomas

Apr 29, 202631 min

S17 Ep10: Evolving Research Puts a Focus on GLP-1 Agonist Use in Breast Cancer: With Sara Nunnery, MD, MSCI; and Neil M. Iyengar, MD

Apr 28, 202623 min

S17 Ep9: Medical Crossfire®: Optimizing ESR1 Mutation Detection and Next-Generation Endocrine Therapy Integration in HR+/HER2– Breast Cancer

Apr 28, 202631 min

S17 Ep17: Localized Bladder Cancer 2026 UPDATE

Apr 27, 202613 min

S17 Ep8: From Molecular Insights to Clinical Impact: Translating the Latest Advances in Menin Inhibitors Into Practice

Apr 27, 202615 min

S17 Ep7: RAS/MAP Kinase Pathway Targeting Makes Strides in Gynecologic Cancer Management: With Ursula A. Matulonis, MD; and Elizabeth H. Stover, MD, PhD

Apr 24, 202617 min

S16 Ep57: Medical Crossfire®: Advancing Personalized Care in TNBC—Integrating Biomarkers, Clinical Evidence, and Emerging Therapies

Apr 24, 202631 min

S16 Ep56: Medical Crossfire® Expanding Options, Evolving Challenges in Advanced HR+/HER2– Breast Cancer: How Experts Apply the Latest Data

Apr 23, 202629 min

S16 Ep50: Show Me the Data: Translating Clinical and Practice-Based Evidence on Oral SERDs Into Everyday Care for HR+/HER2– Metastatic Breast Cancer

Apr 21, 202630 min